Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
London
Biotech
ReNeuron leaving AIM exchange after missing fundraising goal
The stem cell biotech is letting go of its listing after money troubles persuaded it to free itself from the costs and obligations of the exchange.
Nick Paul Taylor
Aug 30, 2024 10:30am
Syncona blames difficult market for falling biotech valuations
Jun 15, 2023 9:20am
CRO hVIVO inks deal to test RSV drug in human challenge trial
Feb 8, 2023 10:10am
AbbVie links up with VC firm to map anti-inflammatory companies
Nov 28, 2022 7:30am
'Day job and a gay job': LGBTQ+ leaders bring biopharma together
Dec 8, 2021 7:00am
London healthcare firm snaps up Velocity Clinical Research
Apr 12, 2021 7:30am
